Newly Released Clinical Study Suggests That Neurostimulation Device May Reduce Both Opioid and Stimulant Use, Offering Hope Amid Nation’s Addiction Crisis
Amid record-high drug overdose rates and no FDA-approved medications for stimulant addiction, a new peer-reviewed study published in Frontiers in Psychiatry found that patients who used NET Recovery's FDA-cleared neurostimulation device, the NET Device™, for at least 24 hours to treat their opioid withdrawal reported significantly fewer days of opioid and stimulant use in the […]